Ownership and insider activity for TransMedics Group, Inc. (TMDX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs.
Price
| Price | $82.73 |
| Market Cap | $2.9B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-21 | Araujo Fernando N. | |||
| 2026-09-11 | Weill David | P-Purchase | 1,336 | $109K |
| 2026-08-17 | TOBIN JAMES R | G-Gift | 18,000 | |
| 2026-07-10 | Corcoran Nicholas | A-Award | 11,727 | |
| 2026-07-10 | Corcoran Nicholas | A-Award | 17,784 | $1.3M |
| 2026-07-10 | Hernandez Gerardo | A-Award | 17,246 | |
| 2026-07-10 | Hernandez Gerardo | A-Award | 26,153 | $1.9M |
| 2026-07-10 | Hassanein Waleed H | A-Award | 49,669 | |
| 2026-07-10 | Hassanein Waleed H | A-Award | 112,984 | $8.0M |
| 2026-06-15 | Gunderson Thomas J. | M-Exempt | 19,285 | $43K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.8M | $11.9M | $20.2M | $20.1M | $24.6M | $25.6M | $201.2M | $394.8M | $336.6M | $488.4M |
| Short-term Investments | $38.0M | $12.7M | 0 | $60.6M | $101.1M | $66.9M | 0 | 0 | 0 | 0 |
| Receivables | $1.4M | $925,000 | $3.4M | $6.6M | $6.9M | $5.9M | $27.6M | $63.6M | $97.7M | $84.3M |
| Inventory | $6.3M | $8.0M | $9.3M | $11.2M | $11.9M | $14.9M | $20.6M | $44.2M | $46.6M | $48.9M |
| Total Current Assets | $55.9M | $34.0M | $34.8M | $100.0M | $146.8M | $118.7M | $252.3M | $510.7M | $497.2M | $637.8M |
| Property, Plant & Equipment | $1.7M | $2.5M | $3.5M | $4.8M | $4.8M | $15.7M | $24.4M | $180.5M | $292.5M | $332.8M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $12.0M | $11.5M | $11.5M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.4M | $2.2M | $1.9M |
| Total Assets | $58.1M | $37.0M | $42.2M | $105.3M | $152.0M | $134.9M | $277.1M | $706.0M | $804.1M | $1.07B |
| Accounts Payable | $4.2M | $3.5M | $4.7M | $7.2M | $1.2M | $6.7M | $3.3M | $12.7M | $10.3M | $10.3M |
| Short-term Debt | 0 | $1.8M | 0 | 0 | 0 | 0 | 0 | 0 | $2.7M | $13.3M |
| Total Current Liabilities | $9.5M | $10.9M | $12.6M | $16.1M | $11.9M | $23.2M | $23.7M | $54.9M | $59.9M | $89.3M |
| Long-term Debt | $8.4M | $6.8M | $33.7M | $34.1M | $34.7M | $35.2M | $58.7M | $506.2M | $509.3M | $456.4M |
| Total Liabilities | $19.3M | $205.7M | $47.0M | $50.6M | $48.1M | $67.0M | $89.8M | $568.8M | $575.5M | $595.3M |
| Retained Earnings | -$291.4M | -$312.2M | -$335.9M | -$369.5M | -$398.2M | -$442.4M | -$478.7M | -$503.7M | -$468.2M | -$277.9M |
| Total Equity | $38.8M | -$168.7M | -$4.8M | $54.6M | $103.9M | $67.9M | $187.4M | $137.2M | $228.6M | $473.1M |
| Total Debt | $8.4M | $8.7M | $33.7M | $34.1M | $34.7M | $43.8M | $67.6M | $515.9M | $518.3M | $469.7M |
| Net Debt | -$39.4M | -$16.0M | $13.4M | -$46.5M | -$91.0M | -$48.7M | -$133.6M | $121.1M | $181.6M | -$18.7M |
| Working Capital | $46.4M | $23.1M | $22.2M | $83.9M | $134.9M | $95.5M | $228.6M | $455.7M | $437.3M | $548.5M |
Related companies: AKRO · BRKR · GKOS · HNGE · IMVT · INDV · KYMR
Explore sector: Healthcare · Medical - Devices
More sections of TMDX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks